Why testing should be top of mind for health plans even amid the COVID-19 vaccine rollout

fiercehealthcare, 22/01/2021

Partagé par : 

Beesens TEAM

Why testing should be top of mind for health plans even amid the COVID-19 vaccine rollout

"While health plans have had to focus on responding to the COVID-19 pandemic, they need to ensure members are continuing to access testing services, both for the virus and for more routine evaluations—or face a crush of demand in the future.
As COVID-19 testing efforts ramped up and the pandemic dragged on, both health plans and patients themselves put less of an emphasis on these tests, so they "languished," Sean Slovenski, CEO of diagnostic testing firm BioIQ, told Fierce Healthcare in an interview.
Continuing to push off routine tests could lead to another wave of requests that slam laboratories and testing facilities, he said.
"The worry now is that there is going to be a huge bolus of people that have been blowing off their routine testing scrambling to get it done now," Slovenski said. "Is there a chance that we can overwhelm the entire diagnostic system again?"
Slovenski said in working with health plans on this issue, BioIQ is counseling them to stay aggressive on COVID-19 while also pushing now for members to start thinking about their routine diagnostics..." Lire la suite